Supernus Pharmaceuticals Inc (SUPN)
Cost of Revenue
$99.03M
TTM · Period ending: · USD
SUPN Cost of Revenue
Latest reported$99.03Mperiod ending
Latest reported$99.03Mperiod ending
SUPN TTM Cost of Revenue ($0.00 → $99.03M)
TTM cost of revenue
High-resolution chart · PNG
SUPN cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 99,032,000 | |
| 82,190,000 | |
| 74,562,000 | |
| 77,653,000 | |
| 76,271,000 | |
| 77,360,000 | |
| 77,906,000 | |
| 71,435,000 | |
| 73,453,000 | |
| 76,628,000 | |
| 83,779,000 | |
| 87,106,000 | |
| 93,383,000 | |
| 92,749,000 | |
| 87,221,000 | |
| 81,261,000 | |
| 73,468,000 | |
| 78,039,000 | |
| 75,061,000 | |
| 76,600,000 | |
| 79,903,000 | |
| 63,261,000 | |
| 52,459,000 | |
| 38,039,000 | |
| 21,470,000 | |
| 17,128,000 | |
| 16,660,000 | |
| 16,735,000 | |
| 16,123,000 | |
| 15,762,000 | |
| 15,356,000 | |
| 15,322,000 | |
| 15,366,000 | |
| 15,544,000 | |
| 15,215,000 | |
| 14,832,000 | |
| 14,009,000 | |
| 12,899,000 | |
| 11,985,000 | |
| 11,008,000 | |
| 9,828,000 | |
| 8,839,000 | |
| 8,422,000 | |
| 7,910,000 | |
| 6,983,000 | |
| 6,882,000 | |
| 5,758,000 | |
| 4,542,000 | |
| 3,254,000 | |
| 1,597,000 | |
| 1,103,000 | |
| 37,000 | |
| 4,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -13,404,000 | |
| -21,992,146 |